Preferential Use of Central Metabolism In Vivo Reveals a Nutritional Basis for Polymicrobial Infection

PLoS Pathogens

Volumn 11, Issue 1, 2015, Pages 1-13

  Alteri, Christopher J ^a   Himpsl, Stephanie D ^a   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FRUCTOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCERALDEHYDE 3 PHOSPHATE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVATE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SERINE; TRANSALDOLASE; TRIOSEPHOSPHATE ISOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GLUCONEOGENESIS; GLYCOLYSIS; MIXED INFECTION; MOUSE; NONHUMAN; NUTRITIONAL REQUIREMENT; PENTOSE PHOSPHATE CYCLE; PROTEIN SYNTHESIS; PROTEUS MIRABILIS; URINARY TRACT INFECTION; ANIMAL; CBA MOUSE; COMPLICATION; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; NUTRITION; PATHOGENICITY; PHYSIOLOGY; PROTEUS INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PROTEUS MIRABILIS;

ANIMALS; COINFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GLYCOLYSIS; HUMANS; MICE; MICE, INBRED CBA; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PROTEUS INFECTIONS; PROTEUS MIRABILIS; TRANSALDOLASE; URINARY TRACT INFECTIONS;

EID: 84923848643     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004601     Document Type: Article

References (65)

1. Eisenreich W, Dandekar T, Heesemann J, Goebel W, (2010) Carbon metabolism of intracellular bacterial pathogens and possible links to virulence. Nat Rev Microbiol 8: 401–412.
2. Somerville GA, Proctor RA, (2009) At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 73: 233–248.
3. Poncet S, Milohanic E, Maze A, Nait Abdallah J, Ake F, et al. (2009) Correlations between carbon metabolism and virulence in bacteria. Contrib Microbiol 16: 88–102.
4. Rohmer L, Hocquet D, Miller SI, (2011) Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol 19: 341–348.
5. Smith H, (2000) Questions about the behaviour of bacterial pathogens in vivo. Philos Trans R Soc Lond B Biol Sci 355: 551–564.
6. Alteri CJ, Mobley HL, (2012) Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol 15: 3–9.
7. Freter R, Brickner H, Botney M, Cleven D, Aranki A, (1983) Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect Immun 39: 676–685.
8. Alteri CJ, Smith SN, Mobley HL, (2009) Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 5: e1000448.
9. Fabich AJ, Jones SA, Chowdhury FZ, Cernosek A, Anderson A, et al. (2008) Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect Immun 76: 1143–1152.
10. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, et al. (2010) Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426–429.
11. Alteri CJ, Lindner JR, Reiss DJ, Smith SN, Mobley HL, (2011) The broadly conserved regulator PhoP links pathogen virulence and membrane potential in Escherichia coli. Mol Microbiol 82: 145–163.
12. Eylert E, Schar J, Mertins S, Stoll R, Bacher A, et al. (2008) Carbon metabolism of Listeria monocytogenes growing inside macrophages. Mol Microbiol 69: 1008–1017.
13. Joseph B, Mertins S, Stoll R, Schar J, Umesha KR, et al. (2008) Glycerol metabolism and PrfA activity in Listeria monocytogenes. J Bacteriol 190: 5412–5430.
14. Joseph B, Przybilla K, Stuhler C, Schauer K, Slaghuis J, et al. (2006) Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J Bacteriol 188: 556–568.
15. Chatterjee SS, Hossain H, Otten S, Kuenne C, Kuchmina K, et al. (2006) Intracellular gene expression profile of Listeria monocytogenes. Infect Immun 74: 1323–1338.
16. Stoll R, Goebel W, (2010) The major PEP-phosphotransferase systems (PTSs) for glucose, mannose and cellobiose of Listeria monocytogenes, and their significance for extra- and intracellular growth. Microbiology 156: 1069–1083.
17. Lucchini S, Liu H, Jin Q, Hinton JC, Yu J, (2005) Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen. Infect Immun 73: 88–102.
18. Noriega FR, Losonsky G, Lauderbaugh C, Liao FM, Wang JY, et al. (1996) Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine. Infect Immun 64: 3055–3061.
19. Cersini A, Martino MC, Martini I, Rossi G, Bernardini ML, (2003) Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants. Infect Immun 71: 7002–7013.
20. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, et al. (2003) Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med 198: 693–704.
21. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, et al. (2000) Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406: 735–738.
22. Munoz-Elias EJ, Upton AM, Cherian J, McKinney JD, (2006) Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol 60: 1109–1122.
23. Munoz-Elias EJ, McKinney JD, (2005) Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 11: 638–644.
24. Tchawa Yimga M, Leatham MP, Allen JH, Laux DC, Conway T, et al. (2006) Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar Typhimurium in BALB/c mice. Infect Immun 74: 1130–1140.
25. Mercado-Lubo R, Gauger EJ, Leatham MP, Conway T, Cohen PS, (2008) A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice. Infect Immun 76: 1128–1134.
26. Mercado-Lubo R, Leatham MP, Conway T, Cohen PS, (2009) Salmonella enterica serovar Typhimurium mutants unable to convert malate to pyruvate and oxaloacetate are avirulent and immunogenic in BALB/c mice. Infect Immun 77: 1397–1405.
27. Bowden SD, Rowley G, Hinton JC, Thompson A, (2009) Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar typhimurium. Infect Immun 77: 3117–3126.
28. Chang DE, Smalley DJ, Tucker DL, Leatham MP, Norris WE, et al. (2004) Carbon nutrition of Escherichia coli in the mouse intestine. Proc Natl Acad Sci U S A 101: 7427–7432.
29. Miranda RL, Conway T, Leatham MP, Chang DE, Norris WE, et al. (2004) Glycolytic and gluconeogenic growth of Escherichia coli O157: H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect Immun 72: 1666–1676.
30. Anfora AT, Halladin DK, Haugen BJ, Welch RA, (2008) Uropathogenic Escherichia coli CFT073 is adapted to acetatogenic growth but does not require acetate during murine urinary tract infection. Infect Immun 76: 5760–5767.
31. Anfora AT, Haugen BJ, Roesch P, Redford P, Welch RA, (2007) Roles of serine accumulation and catabolism in the colonization of the murine urinary tract by Escherichia coli CFT073. Infect Immun 75: 5298–5304.
32. Burall LS, Harro JM, Li X, Lockatell CV, Himpsl SD, et al. (2004) Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold. Infect Immun 72: 2922–2938.
33. Himpsl SD, Lockatell CV, Hebel JR, Johnson DE, Mobley HL, (2008) Identification of virulence determinants in uropathogenic Proteus mirabilis using signature-tagged mutagenesis. J Med Microbiol 57: 1068–1078.
34. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL, (2010) Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog 6: e1001187.
35. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, et al. (2004) Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect Immun 72: 6373–6381.
36. Pearson MM, Yep A, Smith SN, Mobley HL, (2011) Transcriptome of Proteus mirabilis in the Murine Urinary Tract: Virulence and Nitrogen Assimilation Gene Expression. Infect Immun 79: 2619–2631.
37. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, et al. (1990) Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect Immun 58: 1281–1289.
38. Welch RA, Burland V, Plunkett G, 3rdRedford P, Roesch P, et al. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci USA 99: 17020–17024.
39. Hagberg L, Engberg I, Freter R, Lam J, Olling S, et al. (1983) Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 40: 273–283.
40. Brooks T, Keevil CW, (1997) A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol 24: 203–206.
41. Sprenger GA, (1995) Genetics of pentose-phosphate pathway enzymes of Escherichia coli K-12. Arch Microbiol 164: 324–330.
42. Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, et al. (2011) A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80: 1516–1529.
43. Roesch PL, Redford P, Batchelet S, Moritz RL, Pellett S, et al. (2003) Uropathogenic Escherichia coli use d-serine deaminase to modulate infection of the murine urinary tract. Mol Microbiol 49: 55–67.
44. Cai W, Wannemuehler Y, Dell'anna G, Nicholson B, Barbieri NL, et al. (2013) A novel two-component signaling system facilitates uropathogenic Escherichia coli's ability to exploit abundant host metabolites. PLoS Pathog 9: e1003428.
45. Jones BD, Lockatell CV, Johnson DE, Warren JW, Mobley HL, (1990) Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect Immun 58: 1120–1123.
46. Jones BD, Mobley HL, (1988) Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J Bacteriol 170: 3342–3349.
47. Mao XJ, Huo YX, Buck M, Kolb A, Wang YP, (2007) Interplay between CRP-cAMP and PII-Ntr systems forms novel regulatory network between carbon metabolism and nitrogen assimilation in Escherichia coli. Nucleic Acids Res 35: 1432–1440.
48. Schumacher J, Behrends V, Pan Z, Brown DR, Heydenreich F, et al. (2013) Nitrogen and carbon status are integrated at the transcriptional level by the nitrogen regulator NtrC in vivo. MBio 4: e00881–00813.
49. De Lay N, Gottesman S, (2009) The Crp-activated small noncoding regulatory RNA CyaR (RyeE) links nutritional status to group behavior. J Bacteriol 191: 461–476.
50. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, et al. (1998) Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282: 1494–1497.
51. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ, (2000) Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 97: 8829–8835.
52. Allison C, Coleman N, Jones PL, Hughes C, (1992) Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect Immun 60: 4740–4746.
53. Mobley HL, Belas R, Lockatell V, Chippendale G, Trifillis AL, et al. (1996) Construction of a flagellum-negative mutant of Proteus mirabilis: effect on internalization by human renal epithelial cells and virulence in a mouse model of ascending urinary tract infection. Infect Immun 64: 5332–5340.
54. Unden G, Bongaerts J, (1997) Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim Biophys Acta 1320: 217–234.
55. Brogden KA, Guthmiller JM, Taylor CE, (2005) Human polymicrobial infections. Lancet 365: 253–255.
56. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC, (1982) A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146: 719–723.
57. Saverino D, Schito AM, Mannini A, Penco S, Bassi AM, et al. (2011) Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression. FEMS Immunol Med Microbiol 61: 84–93.
58. Croxall G, Weston V, Joseph S, Manning G, Cheetham P, et al. (2011) Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 60: 102–109.
59. Mobley HL, Warren JW, (1987) Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol 25: 2216–2217.
60. Neidhardt FC, Bloch PL, Smith DF, (1974) Culture medium for enterobacteria. J Bacteriol 119: 736–747.
61. Belas R, Erskine D, Flaherty D, (1991) Transposon mutagenesis in Proteus mirabilis. J Bacteriol 173: 6289–6293.
62. Datsenko KA, Wanner BL, (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645.
63. Galen JE, Nair J, Wang JY, Wasserman SS, Tanner MK, et al. (1999) Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun 67: 6424–6433.
64. Lane MC, Alteri CJ, Smith SN, Mobley HL, (2007) Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 104: 16669–16674.
65. Johnson DE, Lockatell CV, Hall-Craigs M, Mobley HL, Warren JW, (1987) Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J Urol 138: 632–635.